Publications by authors named "James Java"

Claim this Profile
W
What proportion of patients with stage 3 ovarian cancer are potentially cured following intraperitoneal chemotherapy? Analysis of the long term (≥10 years) survivors in NRG/GOG randomized clinical trials of intraperitoneal and intravenous chemotherapy in stage III ovarian cancer.
Omali Pitiyarachchi, Michael Friedlander, James J Java, John K Chan, Deborah K Armstrong

Gynecol Oncol· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transkingdom Analysis of the Female Reproductive Tract Reveals Bacteriophages form Communities.
Ferralita S Madere, Michael Sohn, Angelina K Winbush, Breóna Barr, Alex Grier, James Java

Viruses· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Going mobile with primary care: smartphone-telemedicine for asthma management in young urban adults (TEAMS).
Jennifer R Mammen, Judith D Schoonmaker, James Java, Jill Halterman, Marc N Berliant

J Asthma· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development and preliminary results of an Electronic Medical Record (EMR)-integrated smartphone telemedicine program to deliver asthma care remotely.
Jennifer R Mammen, James J Java, Jill Halterman, Marc N Berliant, Amber Crowley

J Telemed Telecare· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Temporal Dysbiosis of Infant Nasal Microbiota Relative to Respiratory Syncytial Virus Infection.
Alex Grier, Ann L Gill, Haeja A Kessler, Anthony Corbett, Sanjukta Bandyopadhyay, James Java

J Infect Dis· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A mixed-methods analysis of younger adults' perceptions of asthma, self-management, and preventive care: "This isn't helping me none".
Jennifer R Mammen, Kelsey Turgeon, Ashley Philibert, Judith D Schoonmaker, James Java

Clin Exp Allergy· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Measuring the Severity of Respiratory Illness in the First 2 Years of Life in Preterm and Term Infants.
Mary T Caserta, Hongmei Yang, Sanjukta Bandyopadhyay, Xing Qiu, Steven R Gill, James Java

J Pediatr· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Differences in presentation and survival of Asians compared to Caucasians with ovarian cancer: An NRG Oncology/GOG Ancillary study of 7914 patients.
Katherine C Fuh, James J Java, John K Chan, Daniel S Kapp, Bradley J Monk

Gynecol Oncol· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mixed-methods content and sentiment analysis of adolescents' voice diaries describing daily experiences with asthma and self-management decision-making.
Jennifer R Mammen, James J Java, Hyekyun Rhee, Arlene M Butz, Jill S Halterman

Clin Exp Allergy· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nomogram for Predicting Individual Survival After Recurrence of Advanced-Stage, High-Grade Ovarian Carcinoma.
Peter G Rose, James J Java, Ritu Salani, Melissa A Geller, Angeles Alvarez Secord

Obstet Gynecol· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Corrigendum to "Does adjuvant chemotherapy dose modification have an impact on the outcome of patients diagnosed with advanced stage ovarian cancer? An NRG Oncology/Gynecologic Oncology Group study" [Gynecol. Oncol. 151 (2018) 18-23].
Alexander B Olawaiye, James J Java, Thomas C Krivak, Michael Friedlander, David G Mutch

Gynecol Oncol· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Does adjuvant chemotherapy dose modification have an impact on the outcome of patients diagnosed with advanced stage ovarian cancer? An NRG Oncology/Gynecologic Oncology Group study.
Alexander B Olawaiye, James J Java, Thomas C Krivak, Michael Friedlander, David G Mutch

Gynecol Oncol· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neonatal gut and respiratory microbiota: coordinated development through time and space.
Alex Grier, Andrew McDavid, Bokai Wang, Xing Qiu, James Java

Microbiome· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of prior vaccination on carriage rates of Streptococcus pneumoniae in older adults: A longitudinal surveillance study.
Angela R Branche, Hongmei Yang, James Java, Jeanne Holden-Wiltse, David J Topham

Vaccine· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient and Physician Perceptions of Virtual Visits for Parkinson's Disease: A Qualitative Study.
Jennifer R Mammen, Molly J Elson, James J Java, Christopher A Beck, Denise B Beran

Telemed J E Health· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Surgical outcomes among elderly women with endometrial cancer treated by laparoscopic hysterectomy: a NRG/Gynecologic Oncology Group study.
Erin A Bishop, James J Java, Kathleen N Moore, Nick M Spirtos, Michael L Pearl

Am J Obstet Gynecol· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictive modeling for determination of microscopic residual disease at primary cytoreduction: An NRG Oncology/Gynecologic Oncology Group 182 Study.
Neil S Horowitz, G Larry Maxwell, Austin Miller, Chad A Hamilton, Bunja Rungruang, James J Java

Gynecol Oncol· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of tumour histology on survival in advanced cervical carcinoma: an NRG Oncology/Gynaecologic Oncology Group Study.
Leigh G Seamon, James J Java, Bradley J Monk, Richard T Penson, Jubilee Brown

Br J Cancer· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pathologic and Treatment Outcomes Among a Geriatric Population of Endometrial Cancer Patients: An NRG Oncology/Gynecologic Oncology Group Ancillary Data Analysis of LAP2.
Erin A Bishop, James J Java, Kathleen N Moore, Joan L Walker

Int J Gynecol Cancer· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Disease extent at secondary cytoreductive surgery is predictive of progression-free and overall survival in advanced stage ovarian cancer: An NRG Oncology/Gynecologic Oncology Group study.
Peter G Rose, James J Java, Mark A Morgan, Angeles Alvarez-Secord, Joshua P Kesterson

Gynecol Oncol· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Does time interval between surgery and intraperitoneal chemotherapy administration in advanced ovarian cancer carry a prognostic impact? An NRG Oncology/Gynecologic Oncology Group study ancillary study.
Arlene E Garcia-Soto, James J Java, Wilberto Nieves Neira, J Matthew Pearson, David E Cohn

Gynecol Oncol· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of histology and surgical approach on survival among women with early-stage, high-grade uterine cancer: An NRG Oncology/Gynecologic Oncology Group ancillary analysis.
Amanda N Fader, James Java, Meaghan Tenney, Stephanie Ricci, Camille C Gunderson

Gynecol Oncol· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The association between timing of initiation of adjuvant therapy and the survival of early stage ovarian cancer patients - An analysis of NRG Oncology/Gynecologic Oncology Group trials.
John K Chan, James J Java, Katherine Fuh, Bradley J Monk, Daniel S Kapp

Gynecol Oncol· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Is age a prognostic biomarker for survival among women with locally advanced cervical cancer treated with chemoradiation? An NRG Oncology/Gynecologic Oncology Group ancillary data analysis.
Kathleen N Moore, James J Java, Katrina N Slaughter, Peter G Rose, Rachelle Lanciano

Gynecol Oncol· November 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk factors for readmission in patients with ovarian, fallopian tube, and primary peritoneal carcinoma who are receiving front-line chemotherapy on a clinical trial (GOG 218): an NRG oncology/gynecologic oncology group study (ADS-1236).
Linda R Duska, James J Java, David E Cohn, Robert A Burger

Gynecol Oncol· November 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis